A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
01/26/2015 | Michael Schubert
A typical estrogen induction of protein pathways leads to treatment resistance and poorer outcomes in some breast cancers
12/22/2014 | Roisin McGuigan
Cell lines that have avoided senescence but kept their normal genome could provide new avenues for cancer research
Point-of-care molecular diagnosis could make a big difference to disease control in remote communities
12/22/2014 | Jacqueline James, Manuel Salto Tellez
Are we ready to meet the demands of modern clinical practice?
11/18/2014 | Tim James
When it comes to quality control in your lab, don’t overlook the obvious – contaminated water can lead to a host of problems.
11/18/2014 | Tibor Tot
A new prognostic index, combining morphological and molecular parameters, is needed to improve breast cancer guidance
11/18/2014 | Roisin McGuigan
Initial results suggest that a graphene biochip is faster and more sensitive than ELISA
11/17/2014 | Sabrina Leslie
Molecular imaging for the normal lab – a simple, cost-effective alternative
11/17/2014 | Arnaud Roth
Pathologists’ involvement in patient care is changing – are you keeping up?
11/17/2014 | Michael Schubert
Sitting Down With… Robert Pierce, Chief Scientific Officer, OncoSec, San Diego, CA, USA
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology